APA (7th ed.) Citation

Gröschel, S. (2015). Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways. Blood, 125(1), . https://doi.org/10.1182/blood-2014-07-591461

Chicago Style (17th ed.) Citation

Gröschel, Stefan. "Mutational Spectrum of Myeloid Malignancies with Inv(3)/t(3;3) Reveals a Predominant Involvement of RAS/RTK Signaling Pathways." Blood 125, no. 1 (2015). https://doi.org/10.1182/blood-2014-07-591461.

MLA (9th ed.) Citation

Gröschel, Stefan. "Mutational Spectrum of Myeloid Malignancies with Inv(3)/t(3;3) Reveals a Predominant Involvement of RAS/RTK Signaling Pathways." Blood, vol. 125, no. 1, 2015, https://doi.org/10.1182/blood-2014-07-591461.